Archives
-
Escitalopram: A Better Lens on Anxiety Evidence
2026-10-06
Escitalopram research is often reduced to serotonin transporter pharmacology or broad treatment outcomes. This article connects 5-HT reuptake inhibition with phenotype, endpoint selection, and moderator analysis to clarify what anxious-depression evidence can—and cannot—show.
-
A-769662 and AMPK: Five Evidence Questions
2026-10-05
A source-grounded overview of A-769662 as an AMPK activator, with emphasis on how it relates to autophagy, ULK1 signaling, energy metabolism regulation, evidence quality, and the limits of translating supplier-reported findings into broader biological or therapeutic conclusions.
-
EPZ5676 and DOT1L: Evidence, Context, and Limits
2026-10-05
A source-grounded overview of EPZ5676 as a research DOT1L inhibitor, covering its reported biochemical and leukemia-model findings, conceptual applications, comparison with melanoma epigenetic studies, and the limitations that prevent direct clinical or immunotherapy extrapolation.
-
Preserving CYR61 Signaling for Translational Proteomics
2026-10-04
A thought-leadership analysis connecting CYR61–integrin signaling, migrasomes, and sample-integrity strategy in irradiated BMSC research. The article explains where an MS-compatible Protease Inhibitor Cocktail can strengthen translational proteomics while distinguishing measurement preservation from biological validation.
-
Ivermectin in Parasitology Research: Evidence and Limits
2026-10-03
Ivermectin is an established broad-spectrum anti-parasitic medicine with important applications in onchocerciasis treatment research, strongyloidiasis research, and parasitology drug development. A separate 2024 pancreatic cancer study identifies GSDMC as a preclinical target, but it provides no evidence that ivermectin affects GSDMC, pancreatic cancer, or cancer immunotherapy.
-
Amitriptyline HCl: Practical CNS Workflow Guide
2026-10-02
Amitriptyline HCl (SKU B2231) provides a defined small-molecule perturbation tool for neurotransmitter receptor modulation, receptor-focused screening, and selected CNS cell workflows. This guide covers preparation, storage, controls, and interpretation boundaries; it should not be treated as evidence of clinical efficacy or as a substitute for model-matched primary literature.
-
Clozapine N-oxide (CNO) for Chemogenetics
2026-10-01
Clozapine N-oxide enables receptor-defined neuronal activity modulation with applications spanning DREADD validation, longitudinal imaging, and sensory-learning studies. This workflow-focused guide explains how to prepare CNO, connect chemogenetic perturbation to subtype-resolved assays, and troubleshoot solubility, timing, and control-design problems.
-
Safe DNA Gel Stain for Safer Liver Assays
2026-10-01
Use Safe DNA Gel Stain to build a blue-light-compatible nucleic acid workflow around senescence and liver-stress experiments. Its flexible gel or post-stain formats support PCR, RNA integrity checks, and cloning while reducing reliance on ethidium bromide and UV exposure.
-
Starvation, ER Calcium, and Cell Fate in Silkworm Fat Body
2026-09-30
A 2026 study in Bombyx mori identifies an ER-Ca2+-calpain axis that converts starvation-induced autophagy into apoptosis in the insect fat body. By combining metabolic, calcium, protease, and cell-death readouts with 2-APB perturbation, the work links nutrient depletion to a time-dependent change in cellular fate while also highlighting the limits of pharmacological pathway assignment.
-
Adefovir (GS-0393) Workflows for HBV Research
2026-09-30
A practical guide to using Adefovir as both an HBV replication probe and an OAT1 transporter substrate. Learn how to design concentration-response studies, distinguish intracellular activation from direct polymerase inhibition, and troubleshoot solubility, timing, and renal transport assays.
-
Ribonuclease R Workflow for Circular RNA Validation
2026-09-29
Learn how to use RNase R for circular RNA enrichment, junction-specific validation, RNA structure analysis, and sequencing preparation. This workflow connects enzyme-based linear RNA depletion with the circ_0042103/TAF15/NER findings in pulpitis while emphasizing controls, interpretation, and troubleshooting.
-
Bedaquiline: Mechanism, Evidence, and Workflows
2026-09-29
Bedaquiline is a diarylquinoline antibiotic that disrupts Mycobacterium tuberculosis energy production through F1FO-ATP synthase inhibition. Its reported mitochondrial and glycolytic effects also support controlled cancer stem cell and metabolism research, while the cited evidence does not establish clinical oncology use.
-
BglII Restriction Endonuclease: Practical Workflow
2026-09-28
BglII Restriction Endonuclease provides rapid cleavage of DNA containing the 5′-AGATCT-3′ recognition site, supporting plasmid DNA digestion, PCR product cleavage, and selected genomic DNA workflows. It should be used when the target sequence and expected digest pattern are known, and it is not intended for diagnostic or medical applications.
-
DiscoveryProbe Stem Cell Compound Library Plus
2026-09-28
Use pathway-focused chemical perturbations to ask how muscle satellite cells balance proliferation, differentiation, and self-renewal—not simply whether cells survive. This guide connects the ASB5 marker study to a practical, control-rich screening workflow using the 280-compound DiscoveryProbe collection.
-
High-Content Screening of Schistosome Stem Cells
2026-09-27
Perera, Chioni and Walker developed an imaging-based platform to quantify dividing neoblasts in developmentally advanced Schistosoma mansoni schistosomula, then used it to prioritize compounds that impaired parasite development and stem-cell proliferation. The study offers a more quantitative route for anti-schistosome screening while highlighting the need to confirm candidate activity across parasite stages and with independent readouts.